These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9242541)

  • 1. The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections.
    van Deuren M; van der Ven-Jongekrijg J; Vannier E; van Dalen R; Pesman G; Bartelink AK; Dinarello CA; van der Meer JW
    Blood; 1997 Aug; 90(3):1101-8. PubMed ID: 9242541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of endotoxin and dexamethasone induces type II interleukin 1 receptor (IL-1r II) in monocytes: a comparison to interleukin 1 beta (IL-1 beta) and interleukin 1 receptor antagonist (IL-1ra).
    Brown EA; Dare HA; Marsh CB; Wewers MD
    Cytokine; 1996 Nov; 8(11):828-36. PubMed ID: 9047079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat stress and/or endotoxin effects on cytokine expression by human whole blood.
    DuBose DA; Balcius J; Morehouse D
    Shock; 2002 Mar; 17(3):217-21. PubMed ID: 11900341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease.
    Ludwiczek O; Vannier E; Borggraefe I; Kaser A; Siegmund B; Dinarello CA; Tilg H
    Clin Exp Immunol; 2004 Nov; 138(2):323-9. PubMed ID: 15498044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotoxin-adapted septic shock leukocytes selectively alter production of sIL-1RA and IL-1beta.
    Mueller LP; Yoza BK; Neuhaus K; Loeser CS; Cousart S; Chang MC; Meredith JW; Li L; McCall CE
    Shock; 2001 Dec; 16(6):430-7. PubMed ID: 11770040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy.
    Vannier E; Kaser A; Atkins MB; Fantuzzi G; Dinarello CA; Mier JW; Tilg H
    Eur Cytokine Netw; 1999 Mar; 10(1):37-42. PubMed ID: 10210771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections.
    van Deuren M; van der Ven-Jongekrijg J; Demacker PN; Bartelink AK; van Dalen R; Sauerwein RW; Gallati H; Vannice JL; van der Meer JW
    J Infect Dis; 1994 Jan; 169(1):157-61. PubMed ID: 8277177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of serum levels of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia.
    Barak V; Nisman B; Polliack A; Vannier E; Dinarello CA
    Eur Cytokine Netw; 1998 Mar; 9(1):33-9. PubMed ID: 9613675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma.
    O'Nualláin EM; Puri P; Mealy K; Reen DJ
    Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):96-101. PubMed ID: 7606873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1beta system (ligand, receptor type I, receptor accessory protein and receptor antagonist), TNF-alpha, TGF-beta1 and neuropeptide Y mRNAs in specific brain regions during bacterial LPS-induced anorexia.
    Ilyin SE; Gayle D; Flynn MC; Plata-Salamán CR
    Brain Res Bull; 1998 Mar; 45(5):507-15. PubMed ID: 9570721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different pattern of interleukin-1 beta-(IL-1 beta), interleukin-1 receptor antagonist- (IL-1ra) and interleukin-1 receptor type I- (IL-1R tI) mRNA-expression in single preimplantation mouse embryos at various developmental stages.
    Kruessel JS; Huang HY; Wen Y; Kloodt AR; Bielfeld P; Polan ML
    J Reprod Immunol; 1997 Sep; 34(2):103-20. PubMed ID: 9292778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1beta production but decreased tumour necrosis factor-alpha production after a 5-km run.
    Drenth JP; Krebbers RJ; Bijzet J; van der Meer JW
    Eur J Clin Invest; 1998 Oct; 28(10):866-72. PubMed ID: 9793002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II.
    Kreuzer KA; Dayer JM; Rockstroh JK; Sauerbruch T; Spengler U
    Clin Exp Immunol; 1997 Jul; 109(1):54-8. PubMed ID: 9218824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-(1-->3)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta/IL-1 receptor antagonist ratio.
    Luhm J; Langenkamp U; Hensel J; Frohn C; Brand JM; Hennig H; Rink L; Koritke P; Wittkopf N; Williams DL; Mueller A
    BMC Immunol; 2006 Mar; 7():5. PubMed ID: 16553947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1beta influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis.
    Kopp S; Alstergren P; Ernestam S; Nordahl S; Bratt J
    Scand J Rheumatol; 2006; 35(3):182-8. PubMed ID: 16766364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome.
    Pruitt JH; Welborn MB; Edwards PD; Harward TR; Seeger JW; Martin TD; Smith C; Kenney JA; Wesdorp RI; Meijer S; Cuesta MA; Abouhanze A; Copeland EM; Giri J; Sims JE; Moldawer LL; Oldenburg HS
    Blood; 1996 Apr; 87(8):3282-8. PubMed ID: 8605344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1beta, IL-1Ra and sIL-1RII in the culture supernatants of PMN and PBMC and the serum levels in patients with inflammation and patients with cancer disease of the same location.
    Jablonska E; Jablonski J; Piotrowski L; Grabowska Z
    Immunobiology; 2001 Dec; 204(4):508-16. PubMed ID: 11776404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis.
    Dewberry R; Holden H; Crossman D; Francis S
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2394-400. PubMed ID: 11073843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 and its soluble receptor during acute meningococcal infections: effect of plasma or whole blood exchange.
    Frieling JT; van Deuren M; Wijdenes J; van Dalen R; Bartelink AK; van der Linden CJ; Sauerwein RW
    Crit Care Med; 1996 Nov; 24(11):1801-5. PubMed ID: 8917028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.
    Molnar C; Garcia-Trevijano ER; Ludwiczek O; Talabot D; Kaser A; Mato JM; Fritsche G; Weiss G; Gabay C; Avila MA; Tilg H
    Eur Cytokine Netw; 2004; 15(4):303-11. PubMed ID: 15627638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.